Evolution of Patients With Sézary Syndrome After Mogamulizumab Discontinuation for Any Cause Except Disease Progression
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study)
Br J Dermatol 2024 Apr 25;[EPub Ahead of Print], S Tzoumpa, S Ingen-Housz-Oro, A de Masson, A Pham-Ledard, T El Aarbaoui, O Dereure, G Quereux, S Faiz, M de Vicq de Cumptich, C Ram-Wolff, R Janela-Lapert, E Guenova, C Lheure, Y Le Corre, H Adamski, M Blanchard, N Bonnet, F Amatore, F Grange, L Troin, M Bagot, M Beylot-BarryFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.